These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections. Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264 [TBL] [Abstract][Full Text] [Related]
7. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164 [TBL] [Abstract][Full Text] [Related]
8. Interaction of uropathogenic Escherichia coli with host uroepithelium. Kau AL; Hunstad DA; Hultgren SJ Curr Opin Microbiol; 2005 Feb; 8(1):54-9. PubMed ID: 15694857 [TBL] [Abstract][Full Text] [Related]
9. Immunological approach to the pathogenetical role of Escherichia coli adhesive factor "119" in a suckling mouse urinary tract model. Kétyi I Acta Microbiol Acad Sci Hung; 1982; 29(2):123-7. PubMed ID: 6127911 [TBL] [Abstract][Full Text] [Related]
10. A toll-like receptor that prevents infection by uropathogenic bacteria. Zhang D; Zhang G; Hayden MS; Greenblatt MB; Bussey C; Flavell RA; Ghosh S Science; 2004 Mar; 303(5663):1522-6. PubMed ID: 15001781 [TBL] [Abstract][Full Text] [Related]
11. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice. Layton GT; Smithyman AM Clin Exp Immunol; 1983 Nov; 54(2):305-12. PubMed ID: 6360434 [TBL] [Abstract][Full Text] [Related]
12. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. Nesta B; Spraggon G; Alteri C; Moriel DG; Rosini R; Veggi D; Smith S; Bertoldi I; Pastorello I; Ferlenghi I; Fontana MR; Frankel G; Mobley HL; Rappuoli R; Pizza M; Serino L; Soriani M mBio; 2012; 3(2):. PubMed ID: 22496310 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection. Habibi M; Asadi Karam MR; Bouzari S Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265 [TBL] [Abstract][Full Text] [Related]
14. [Effects of vaccination in urinary infections caused by Escherichia coli in rats]. Mathieu D; Jacques L; Auer J; Bizzini B Biomed Pharmacother; 1987; 41(8):442-5. PubMed ID: 3330459 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of the innate immune response of bladder epithelial cells by Astragalus polysaccharides through upregulation of TLR4 expression. Yin X; Chen L; Liu Y; Yang J; Ma C; Yao Z; Yang L; Wei L; Li M Biochem Biophys Res Commun; 2010 Jun; 397(2):232-8. PubMed ID: 20546703 [TBL] [Abstract][Full Text] [Related]
16. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Mulvey MA; Schilling JD; Hultgren SJ Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001 [TBL] [Abstract][Full Text] [Related]
17. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae. Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977 [TBL] [Abstract][Full Text] [Related]